Back

18F-FDG PET/CT metabolic parameters predict prognosis in pancreatic ductal adenocarcinoma after neoadjuvant chemotherapy

2026-03-03 gastroenterology Title + abstract only
View on medRxiv
Show abstract

This study aimed to evaluate the prognostic value of quantitative analysis of {superscript 1}F-FDG positron emission tomography (PET)/computed tomography (CT) metabolic parameters in patients with pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant chemotherapy (NACT). A retrospective analysis was conducted on the clinical and imaging data of 44 patients with pathologically confirmed PDAC who received NACT. All patients completed standard chemotherapy regimens and underwent {superscript 1}...

Predicted journal destinations